Accessibility Menu
Protect Pharmaceutical logo

Protect Pharmaceutical(OTC) PRTT

Market Cap$11.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-99%
5 Year-75%
1 Year-64%
1 Month-58%
$0.20
-16.96%
-0.04Today
Protect Pharmaceutical last closing stock price
MetricPriceDate
Last closeUSD 0.202026-08-27
Protect Pharmaceutical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-20.28%USD 0.252026-08-20
1 month-58.39%USD 0.482026-07-28
3 month+240.39%USD 0.062026-05-27
Year to date+116.16%USD 0.092025-12-31
1 year-63.69%USD 0.552025-08-27
3 year-65.04%USD 0.572023-08-28
5 year-74.77%USD 0.792021-08-27
Since inception-99%USD 20.002006-08-01

Protect Pharmaceutical Financials at a Glance

Market Cap

$11.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$52.00M

Net Income (TTM)

$13.17M

EPS (TTM)

$0.86

P/E Ratio

0.23

Dividend

$0.00

Beta (Volatility)

0.96 (Low)

Price

$0.20

Volume

7,533

Open

$0.22

Previous Close

$0.20

Daily Range

$0.15 - $0.22

52-Week Range

$0.02 - $0.62

Estimated Earnings Date

Jul 8, 2024

PRTT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Protect Pharmaceutical

Protect Pharmaceutical Corporation is a company focused on crop farming and agricultural businesses. It operates the Can Noguera property in Spain, which encompasses extensive arable land and resources. Founded in 1987 and based in Las Vegas, Nevada, the company has evolved significantly since its inception.

Products and Services
  • Crop farming and agricultural production
  • Management of arable land and natural resources
  • Acquisition and development of agricultural properties
Growth Outlook
  • Recent revenue of $26.3 million indicates strong market demand
  • Net income of $6.6 million reflects effective cost management
  • Operating income margin of 33.6% showcases operational efficiency
Financial Highlights
  • Trailing twelve months (TTM) P/E ratio of 2.5 suggests potential undervaluation
  • Current ratio of 3.37 indicates strong liquidity position
  • Net profit margin of 25.2% demonstrates profitability
Protect Pharmaceutical Corporation has shown resilience and growth potential in the agricultural sector. The recent quarterly performance highlights a significant revenue stream, with a notable net income that underscores effective management strategies. The company's strong liquidity position, as indicated by the current ratio, provides a solid foundation for future investments and operational expansions. With a low P/E ratio, the company may present an attractive opportunity for investors looking for value in the agricultural industry. The focus on sustainable farming practices and resource management aligns with current market trends, positioning Protect Pharmaceutical Corporation for continued growth and success.
AI Generated • Aug 16, 2026

Industry

Pharmaceuticals

CEO

Boris Stepanov

Headquarters

Las Vegas, NV 89115, US

PRTT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-0.01%

Return on Capital

-0.00%

Return on Assets

-0.01%

Earnings Yield

4.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

57.45M

Volume

7.53K

Avg. Volume

23.94K

Financials (TTM)

Gross Profit

$29.06M

Operating Income

$17.57M

EBITDA

$17.57M

Operating Cash Flow

$6.18M

Capital Expenditure

-$3.49M

Free Cash Flow

$2.69M

Cash & ST Invst.

$75.76M

Total Debt

$4.41M

Protect Pharmaceutical Performance Analysis

Protect Pharmaceutical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 81,799,0003.8%
20232023-12-31USD 136,158,00066.5%
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Protect Pharmaceutical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-13.7%
Q22025-06-302.6%
Q12026-03-31N/A
Q22026-06-30N/A
Protect Pharmaceutical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.4318.4%
20232023-12-31USD 0.8088.0%
20242024-12-31USD 0.9822.7%
20252025-12-31USD -5.79N/A
Protect Pharmaceutical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-38.9%
Q22025-06-309.1%
Q12026-03-31N/A
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$11.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$19.08K

N/A

Employees

600

N/A

Net Income

-$20.00K

-100.2%

EBITDA

-$20.00K

-100.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$75.76M

+20.2%

Total Debt

$4.41M

+14.1%

Accounts Receivable

$60.64M

-12.7%

Inventory

$124.77M

+50.3%

Long Term Debt

$0.00

N/A

Short Term Debt

$4.41M

+14.1%

Return on Assets

-0.01%

N/A

Return on Invested Capital

-0.01%

N/A

Free Cash Flow

-$4.57M

-276.9%

Operating Cash Flow

-$2.10M

-181.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CVVIFSociedad Comercial del Plata S.A.
$0.00+0.00%
CWSFFCielo Waste Solutions Corp.
$0.05+5.18%
CRWECrown Equity Holdings Inc.
$0.86+0.00%
ETCCEnvironmental Tectonics Corporation
$1.54-7.78%

Trending Stocks

Symbol / CompanyPricePrice Chg
IRENIren
$40.53+0.02%
NVDANvidia
$227.98+0.09%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$45.35-0.06%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$123.05+0.06%

Questions About PRTT

What is the current price of Protect Pharmaceutical?

Protect Pharmaceutical is trading at $0.20 per share.

What is the 52-week range for Protect Pharmaceutical?

Over the past 52 weeks, Protect Pharmaceutical has traded between $0.02 and $0.62.

How much debt does Protect Pharmaceutical have?

As of the most recent reporting period, Protect Pharmaceutical reported total debt of $4.50K.

How much cash does Protect Pharmaceutical have on hand?

Protect Pharmaceutical reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Protect Pharmaceutical’s dividend yield?

Protect Pharmaceutical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.